Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glioblastoma.

C Ryan Miller1, Arie Perry

  • 1Division of Neuropathology, Department of Pathology and Immunology, Washington University School of Medicine, 660 S Euclid, St Louis, MO 63110, USA.

Archives of Pathology & Laboratory Medicine
|May 23, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stratification by Ki-67 Labeling Index Increases Specificity of p16<sup>INK4a</sup> Expression as a Surrogate Marker for CDKN2A Inactivation in Meningioma.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same author

Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk Meningioma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Prospective Genomic Profiling of Consecutive Meningiomas.

JAMA oncology·2026
Same author

Laser insterstitial thermal therapy followed by craniotomy for tumor resection for pediatric diffuse midline glioma: illustrative case.

Journal of neurosurgery. Case lessons·2026
Same author

Alpha-B-crystallin immunohistochemistry: A sensitive but non-specific marker for epileptogenic lesions.

Brain pathology (Zurich, Switzerland)·2026
Same author

Intracranial mesenchymal tumor, FET::CREB fusion-positive: An integrative analysis of 81 cases.

Neuro-oncology·2026
Same journal

Assessing Human Epidermal Growth Factor Receptor 2 in Urothelial Carcinoma: Insights From Clinical Practice Into Scoring Criteria, Histologic Subtypes, and Genomic Characteristics Across Disease Sites.

Archives of pathology & laboratory medicine·2026
Same journal

Cross-Reactivity of TPIT Antibody Clone OTI2G1 in Chordoma: Structural Mechanisms and Diagnostic Implications.

Archives of pathology & laboratory medicine·2026
Same journal

Paracoccidioidomycosis at Autopsy: A Case Series and Literature Review.

Archives of pathology & laboratory medicine·2026
Same journal

Accuracy of Cytology Diagnosis for Well Differentiated Neuroendocrine Tumors: Assessment by the College of American Pathologists Non-Gynecologic Slide Program.

Archives of pathology & laboratory medicine·2026
Same journal

Serum Immunofixation Electrophoresis Guidance Conflict: A Call to Harmonize.

Archives of pathology & laboratory medicine·2026
Same journal

In Reply.

Archives of pathology & laboratory medicine·2026
See all related articles

Glioblastoma (GBM) shows diverse morphology, challenging classification. Accurate subtyping is crucial for better prognosis and treatment of this aggressive brain cancer.

Area of Science:

  • Neuropathology
  • Oncology
  • Molecular Genetics

Background:

  • Glioblastoma (GBM) is the most common primary brain malignancy with poor outcomes.
  • Current World Health Organization classification recognizes only 3 GBM variants.
  • New variants with overlapping features, like anaplastic oligodendroglioma, require further study.

Purpose of the Study:

  • To review the morphologic and molecular diversity of established and novel GBM variants.
  • To outline diagnostic approaches for these heterogeneous tumors.
  • To differentiate GBM variants from other high-grade gliomas.

Main Methods:

  • Review of published literature.
  • Analysis of case experience from a diagnostic surgical neuropathology practice.

Related Experiment Videos

Main Results:

  • Glioblastoma exhibits significant morphologic and molecular heterogeneity.
  • Distinguishing GBM variants from other gliomas can be challenging due to overlapping features.
  • Emerging variants may necessitate updates to current classification systems.

Conclusions:

  • Precise subclassification of Glioblastoma is essential for accurate prognostication.
  • Appropriate treatment planning relies on detailed tumor subtyping.
  • Further research into GBM variants will refine diagnostic criteria and therapeutic strategies.